Prospective, multicenter, randomized phase III trial evaluating the impact of lymphoscintigraphy as part of sentinel node biopsy in early breast cancer: SenSzi (GBG80) Trial - Kümmel, Sherko; Holtschmidt, Johannes Claus; Gerber, Bernd; Assen, Albert von der; Heil, Jörg; Thill, Marc; Krug, David; Schem, Christian; Denkert, Carsten; Lubitz, Juliane; Blohmer, Jens-Uwe; Reinisch, Mattea (Journal of clinical oncology, 2019)
Gesehen am 08.11.2019